使用本網站需要啟用 JavaScript, 請啟用后刷新頁面獲得更好的體驗
亚洲精品午夜精品,日本二手网站,国产AⅤ爽AV久久久久成人社区,日本一二三区不收费av
<span id="4vlwo"><table id="4vlwo"></table></span>
<rp id="4vlwo"><optgroup id="4vlwo"><legend id="4vlwo"></legend></optgroup></rp>
<bdo id="4vlwo"></bdo>
<bdo id="4vlwo"><rt id="4vlwo"><dd id="4vlwo"></dd></rt></bdo>
登錄
注冊
首頁
個人居家檢測
臨床應用研究
科研合作項目
合作與服務
社區
純合片段分析
姓氏祖源
祖源平均臉
基因關系
基因保險助手
原始數據
使用 WeGene 需要啟用 Cookies, 請啟用后刷新頁面獲得更好的體驗
社區首頁
小組
術后惡心和嘔吐
術后惡心和嘔吐
發起討論
術后惡心和嘔吐
4 個討論
只看精華帖
按熱門排序
按最新排序
0.03居然還是中招了
WeGene_5410E28C
? 最后回復
喝醉的ROBO1基因
?
2019-06-03 18:40
2393
2
? 來自相關小組
10.17倍
sunke678
? 最后回復
戴帽的DMRT2基因
?
2019-06-03 16:22
2216
2
? 來自相關小組
10.91倍
Flora68
? 2019-04-06 09:46
2322
0
? 來自相關小組
與實際情況不符
剛毅的OTC基因
? 2016-11-19 21:47
2943
0
? 來自相關小組
發起討論
術后惡心和嘔吐
4 個討論
相關基因
ANKK1
位點：RS1800497
Pohjalainen T, et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. 1998
Klein TA, et al. Genetically determined differences in learning from errors. 2007
Blum K, et al. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. 1996
Munafò MR, et al. Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial. 2009
David SP, et al. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. 2007
Spellicy CJ, et al. A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. 2014
Jiang X, et al. Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells. 2014
S?derqvist S, et al. Polymorphisms in the dopamine receptor 2 gene region influence improvements during working memory training in children and adolescents. 2014
McAllister TW, et al. Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study. 2008
Esposito-Smythers C, et al. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. 2009
Doehring A, et al. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. 2009
Lucht M, et al. Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients. 2010
van Strien T, et al. Parental control and the dopamine D2 receptor gene (DRD2) interaction on emotional eating in adolescence. 2010
Doehring A, et al. Genetic diagnostics of functional variants of the human dopamine D2 receptor gene. 2009
Breitling LP, et al. Prospective association of dopamine-related polymorphisms with smoking cessation in general care. 2010
Miller DK, et al. Acute intravenous synaptamine complex variant KB220? "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports. 2010
van der Zwaluw CS, et al. Risky alcohol use in adolescence: the role of genetics (DRD2, SLC6A4) and coping motives. 2011
Li Y, et al. Single nucleotide polymorphism genotyping and point mutation detection by ligation on microarrays. 2011
Stapleton JA, et al. Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy. 2011
Fernàndez-Castillo N, et al. Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample. 2010
Chen D, et al. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies. 2011
Verde Z, et al. 'Smoking genes': a genetic association study. 2011
Lim J, et al. Dopaminergic polymorphisms associated with time-on-task declines and fatigue in the Psychomotor Vigilance Test. 2012
Bakker PR, et al. Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study. 2012
Winkler JK, et al. TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. 2012
Davis C, et al. Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. 2012
Neville MJ, et al. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. 2004
Hawi Z, et al. Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder. 2005
Hu J, et al. No evidence for a major role of polymorphisms during bupropion treatment. 2006
Parsons MJ, et al. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. 2007
Ton TG, et al. Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study. 2007
Yacubian J, et al. Gene-gene interaction associated with neural reward sensitivity. 2007
Elovainio M, et al. Genetic variants in the DRD2 gene moderate the relationship between stressful life events and depressive symptoms in adults: cardiovascular risk in young Finns study. 2007
Keltikangas-J?rvinen L, et al. Dopamine receptor D2 gene Taq1A (C32806T) polymorphism modifies the relationship between birth weight and educational attainment in adulthood: 21-year follow-up of the Cardiovascular Risk in Young Finns study. 2007
Zhang Y, et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. 2007
Sand PG, et al. A lesson not learned: allele misassignment. 2007
Childs E, et al. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. 2008
Bombin I, et al. DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents. 2008
Huang W, et al. Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. 2009
Prasad P, et al. Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. 2008
Perkins KA, et al. Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. 2008
Shi J, et al. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. 2008
Thelma B, et al. Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics. 2008
van der Zwaluw CS, et al. Interaction between dopamine D2 receptor genotype and parental rule-setting in adolescent alcohol use: evidence for a gene-parenting interaction. 2010
Boettiger CA, et al. Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. 2009
Hirvonen MM, et al. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. 2009
Saraswathy KN, et al. Haplotype diversity and linkage disequilibrium at DRD2 locus--a study on four population groups of Andhra Pradesh, India. 2009
Jocham G, et al. Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. 2009
Englund A, et al. NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. 2009
Ponce G, et al. The ANKK1 kinase gene and psychiatric disorders. 2009
Hou QF, et al. Potential association of DRD2 and DAT1 genetic variation with heroin dependence. 2009
Arbouw ME, et al. Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease. 2009
Roe BE, et al. Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene. 2009
Flegontova OV, et al. Haplotype frequencies at the DRD2 locus in populations of the East European Plain. 2009
Dubertret C, et al. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes. 2010
Prasad P, et al. Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. 2010
Sj?holm LK, et al. CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. 2010
Pinheiro AP, et al. The Genetics of Anorexia Nervosa: Current Findings and Future Perspectives. 2015
Ma J, et al. [DRD2/ANKK1 Taq IA polymorphism and early infant temperament]. 2010
Nemoda Z, et al. Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. 2010
Sizoo B, et al. Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders? 2010
Lobo DS, et al. Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. 2010
Bolton JL, et al. Association between polymorphisms of the dopamine receptor D2 and catechol-o-methyl transferase genes and cognitive function. 2010
Walter NT, et al. Interaction effect of functional variants of the BDNF and DRD2/ANKK1 gene is associated with alexithymia in healthy human subjects. 2011
Zhang JP, et al. Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. 2011
Porcelli S, et al. Pharmacogenetics of antidepressant response. 2011
Koehler S, et al. Resting posterior minus frontal EEG slow oscillations is associated with extraversion and DRD2 genotype. 2011
McGuire V, et al. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. 2011
Wilcox CS, et al. ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data. 2011
V?lter C, et al. Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach. 2012
Varga G, et al. Additive effects of serotonergic and dopaminergic polymorphisms on trait impulsivity. 2012
Voisey J, et al. A DRD2 and ANKK1 haplotype is associated with nicotine dependence. 2012
Nyman ES, et al. Sex-specific influence of DRD2 on ADHD-type temperament in a large population-based birth cohort. 2012
Swagell CD, et al. DRD2 C957T and TaqIA genotyping reveals gender effects and unique low-risk and high-risk genotypes in alcohol dependence. 2012
Olfson E, et al. Convergence of genome-wide association and candidate gene studies for alcoholism. 2012
Savitz J, et al. DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder. 2013
Wong PC, et al. Linguistic grammar learning and DRD2-TAQ-IA polymorphism. 2013
Vereczkei A, et al. Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. 2013
David SP, et al. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. 2013
Roth CL, et al. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention. 2013
Bühler KM, et al. Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures. 2014
Spellicy CJ, et al. A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. 2014
Lin H, et al. Living in the moment: effects of time perspective and emotional valence of episodic thinking on delay discounting. 2014
Jiang X, et al. Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells. 2014
S?derqvist S, et al. Polymorphisms in the dopamine receptor 2 gene region influence improvements during working memory training in children and adolescents. 2014
Thaler L, et al. Epistatic interactions implicating dopaminergic genes in bulimia nervosa (BN): relationships to eating- and personality-related psychopathology. 2012
Mignini F, et al. DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: association and gene-gene interaction study in a population of Central Italy. 2012
Wahlstrom LC, et al. DRD2/ANKK1 TaqI A genotype moderates the relationship between alexithymia and the relative value of alcohol among male college binge drinkers. 2012
Roetker NS, et al. Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study. 2012
Ghosh J, et al. Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility. 2013
McClure JB, et al. Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. 2013
Lawford BR, et al. DRD2/ANKK1 Taq1A (rs 1800497 C>T) genotypes are associated with susceptibility to second generation antipsychotic-induced akathisia. 2013
Spellicy CJ, et al. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. 2013
Ramos EM, et al. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. 2013
Hirasawa-Fujita M, et al. Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder. 2014
Zozulinsky P, et al. Dopamine system genes are associated with orienting bias among healthy individuals. 2014
Zhang C, et al. Identification of ANKK1 rs1800497 variant in schizophrenia: new data and meta-analysis. 2014
Yue JK, et al. Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury. 2015
Pan YQ, et al. Association between ANKK1 (rs1800497) polymorphism of DRD2 gene and attention deficit hyperactivity disorder: a meta-analysis. 2015
Kang SG, et al. DRD2 genotypic and haplotype variation is associated with improvements in negative symptoms after 6 weeks' amisulpride treatment. 2015
Li H, et al. Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid. 2015
查看參考文獻
首頁
個人基因檢測
臨床應用研究
科研合作項目
合作與服務
示例報告
下載 APP
社區
關于 WeGene
關于我們
媒體新聞
倫理委員會
隱私協議
加入我們
服務協議
價格保護
幫助中心
關于基因檢測
賬戶購買
樣本寄送
報告解讀
隱私安全
關于第三方數據
社區分享
開放平臺
申請成為開發者
開發文檔
客服微信公眾號
聯系我們
客服郵箱：
[email protected]
合作咨詢：
[email protected]
© 2025 WeGene. All Rights Reserved
深圳市市場監督管理局企業主體身份公示
|
粵ICP備15012185號
| 互聯網藥品信息服務資格證書:（粵）-非經營性-2023-0379
中文
English
<track id="ffr4e"></track>
<dfn id="ffr4e"></dfn>
主站蜘蛛池模板：
新疆
|
康平县
|
东阳市
|
沾益县
|
嵊泗县
|
集贤县
|
宁化县
|
静海县
|
呼伦贝尔市
|
新竹市
|
涟水县
|
武乡县
|
平乐县
|
南乐县
|
永春县
|
明光市
|
高要市
|
西乌珠穆沁旗
|
雷波县
|
德清县
|
罗城
|
左云县
|
河北区
|
自治县
|
申扎县
|
黑龙江省
|
石家庄市
|
渭源县
|
建始县
|
新和县
|
如东县
|
西贡区
|
海伦市
|
宿州市
|
常山县
|
哈巴河县
|
五原县
|
道孚县
|
阿尔山市
|
曲麻莱县
|
阜阳市
|
純合片段分析
姓氏祖源
祖源平均臉
基因關系
基因保險助手
原始數據
深圳市市場監督管理局企業主體身份公示
中文
English